Janus Henderson Investors

Other nine-digit financings go to Airna, Atsena, Neurona

With $105M in venture funding, Bambusa has moved quickly towards the clinic with bispecifics in-licensed from antibody powerhouse Biotheus

Plus fundings around the globe for Eg 427, Atrandi and Reverb

Newco, led by ex-Seagen CEO Epstein, announces $140M series A

Nvelop CEO Jeff Walsh will lead nChroma, which has $75M in new funding and a lead for HBV

Plus: TG Therapeutics’ $250M term loan, and public raises by Tenax, MindMed

Plus: Flagship-backed Abiologics launches; and rounds for GRO, Autobahn and Rona

Plus: New funds for Sands and NewVale, and series C rounds for Lycia and Ajax

Plus Eliem, Century raise private placements as they make acquisitions; Nurix’s AACR readout precedes follow-on; Skye uplists

Plus: Immunic eyes $240M private placement and updates from Applied Therapeutics and Novartis